Royalty Pharma plc (FRA:RPD)

Royalty Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,064	10,948	11,306	16,312	15,050	15,881
Market Cap Growth	-0.75%	-3.17%	-30.69%	8.38%	-5.23%	-
Enterprise Value	20,550	20,604	19,119	25,576	23,466	23,224
Last Close Price	28.22	24.05	23.95	33.69	32.95	-
PE Ratio	11.93	13.20	11.01	407.00	27.62	39.23
PS Ratio	5.76	5.01	5.31	7.79	7.48	9.15
PB Ratio	1.33	1.10	1.24	1.83	1.67	1.96
P/TBV Ratio	1.95	1.63	1.92	3.11	2.97	4.06
P/OCF Ratio	4.83	4.09	4.18	8.13	8.48	9.55
EV/Sales Ratio	10.29	9.42	8.98	12.22	11.66	13.39
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88
EV/EBIT Ratio	11.94	16.51	14.16	29.62	18.65	17.11
Debt / Equity Ratio	0.78	0.74	0.61	0.75	0.69	0.59
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Quick Ratio	1.56	1.43	7.78	2.11	16.77	8.73
Current Ratio	1.56	1.44	7.90	2.19	16.81	8.76
Return on Equity (ROE)	18.00%	13.03%	17.34%	2.33%	12.32%	21.22%
Return on Assets (ROA)	7.04%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital (ROIC)	7.11%	4.73%	5.68%	3.39%	5.41%	7.38%
Return on Capital Employed (ROCE)	11.60%	7.60%	9.20%	5.90%	8.20%	10.60%
Earnings Yield	8.38%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	2.66%	3.37%	3.02%	2.11%	1.81%	-
Payout Ratio	34.60%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield / Dilution	1.86%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Shareholder Return	4.53%	4.83%	-34.63%	-3.48%	-8.67%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.